KEESHA PIERCE: Open Payments
NPI 1366758153 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 119 payments from 22 companies in 2025. Trend: 2023 $2,421 · 2024 $2,302 · 2025 $3,160
Food & beverage: $2,806Education: $354
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $622 |
| Janssen Biotech, Inc. | 23 | $576 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $373 |
| ABBVIE INC. | 11 | $250 |
| Galderma Laboratories, L.P. | 9 | $235 |
| Arcutis Biotherapeutics, Inc. | 4 | $180 |
| Organon LLC | 8 | $128 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| LEO Pharma Inc. | 5 | $98 |
| GENZYME CORPORATION | 5 | $97 |
Products named: Bimzelx, TREMFYA, SKYRIZI, AKLIEF, ILUMYA, Zoryve, DUPIXENT, DAXXIFY.
Industry payments across NV — which companies pay providers there.
